The pathogenetic mechanisms underlying this disease are complex and not yet completely deciphered; in fact, mutations in the same IGHMBP2 gene can determine very serious (SMARD1) or mild phenotypes (CMT). Here, IGHMBP2 is linked to Spinal muscular atrophy with respiratory distress type 1.